These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 378898
41. A prospective study of postacute viral hepatitis: the role of HBsAg. Stanciu L, Urcan S, Părău N, Radu D, Popescu S. Med Interne; 1986; 24(1):19-22. PubMed ID: 3704499 [Abstract] [Full Text] [Related]
42. Dane particles-associated hepatitis B core antigen in patients with HBsAg-positive chronic hepatitis. Sagnelli E, Vernace SJ, Paronetto F. Gastroenterology; 1978 Nov; 75(5):864-8. PubMed ID: 700328 [Abstract] [Full Text] [Related]
43. [Active chronic hepatitis caused by the B virus (ACH-B). Recent pathogenetic acquisitions and elements of serological, clinical and histopathological diagnosis]. Romeo F, Spina A, Cannaò G. Recenti Prog Med; 1980 Dec; 69(6):577-643. PubMed ID: 6166032 [No Abstract] [Full Text] [Related]
44. [Treatment of chronic hepatitis B]. Carreño V, Montaño L, Torres M. Rev Clin Esp; 1983 Oct 15; 171(1):73-6. PubMed ID: 6197728 [No Abstract] [Full Text] [Related]
45. Medical treatment of chronic hepatitis. Results of a retrospective study. Thaler H. Tokai J Exp Clin Med; 1980 Jul 15; 5(3):361-6. PubMed ID: 7222126 [Abstract] [Full Text] [Related]
46. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Gastroenterology; 1981 Dec 15; 81(6):987-91. PubMed ID: 7286593 [Abstract] [Full Text] [Related]
49. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity? Gessoni G, Manoni F. Eur J Med; 1992 Sep 15; 1(5):288-94. PubMed ID: 1285245 [Abstract] [Full Text] [Related]
50. [Distribution of the antigen of hepatitis B virus in liver tissue in healthy carriers and in patients with chronic active and acute hepatitis]. Garciá-Ruiz H, Sotto-Escobar A, Gra-Oramas B. Rev Gastroenterol Mex; 1989 Sep 15; 54(2):87-90. PubMed ID: 2772481 [Abstract] [Full Text] [Related]
51. [Humoral and cellular immunoreactions against HBsAg and liver-specific proteins in the course of acute and chronic hepatitis]. Realdi G, Alberti A, Bortolotti F, Tremolada F, Diodati G, Cadrobbi P. Minerva Gastroenterol; 1976 Sep 15; 22(3):207-12. PubMed ID: 1004755 [No Abstract] [Full Text] [Related]
53. Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases. Smith MG, Eddleston AL, Williams R. Clin Gastroenterol; 1975 May 15; 4(2):297-313. PubMed ID: 1092487 [No Abstract] [Full Text] [Related]
54. [Clinical significance of anti-HB demonstration for post-transfusion hepatitis]. Lehmann H, Gerlich W, Schlaak M. Verh Dtsch Ges Inn Med; 1975 May 15; 83():578-81. PubMed ID: 612038 [No Abstract] [Full Text] [Related]
55. [Autoimmune hepatitis. Forms of manifestation, diagnosis and treatment]. Poulsen LO, Tage-Jensen U, Vyberg M. Ugeskr Laeger; 1992 Aug 10; 154(33):2259-63. PubMed ID: 1413130 [Abstract] [Full Text] [Related]
56. Type B hepatitis: progression to chronic hepatitis. Wright R. Clin Gastroenterol; 1980 Jan 10; 9(1):97-115. PubMed ID: 6994954 [Abstract] [Full Text] [Related]